Exploris Health develops AI-driven multi-marker algorithms for non-invasive cardiac diagnostics, specifically targeting the detection of life-threatening coronary artery blockages. Their Cardio Explorer® test enhances ischemia prediction accuracy, improving patient safety and treatment outcomes in cardiovascular care.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for detecting coronary artery disease often involve invasive procedures or lack the accuracy needed for early diagnosis, leading to delayed treatment and increased risk of adverse cardiac events. Traditional diagnostic approaches may also expose patients to unnecessary radiation or contrast agents.
Solution
Exploris Health offers Cardio Explorer®, a non-invasive diagnostic test that uses AI-driven multi-marker algorithms to detect life-threatening coronary artery blockages. By analyzing complex data structures, the platform enhances ischemia prediction accuracy, providing physicians with a more reliable assessment of a patient's risk for coronary heart disease. The test aims to improve patient safety by reducing the need for invasive procedures and enabling earlier intervention.
Target Audience
The primary target audience includes cardiologists, general practitioners, and healthcare providers involved in cardiac diagnostics, as well as patients at risk of or suspected of having coronary artery disease.
Features
- AI-driven analysis of multi-marker data for enhanced ischemia prediction
- Non-invasive diagnostic approach, reducing patient risk and discomfort
- Identification of life-threatening coronary artery constrictions
- Integration of data science and predictive modeling for personalized therapy
- Intended to improve the management of patients with suspected coronary artery disease